Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2006, p. 4448-4461, Vol. 26, No. 12
0270-7306/06/$08.00+0 doi:10.1128/MCB.02101-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Elzbieta Wloga,
Benedetta Naglieri,
John Abrashkin,
Kapil Verma, and
Lili Yamasaki*
Department of Biological Sciences, Columbia University, New York, New York 10027
Received 28 October 2005/ Returned for modification 30 November 2005/ Accepted 12 March 2006
Although many E2F target genes have been identified recently, very little is
known about how any single E2F site controls the expression of an E2F
target gene in vivo. To test the requirement for a single E2F site in
vivo and to learn how E2F-mediated repression is regulated during
development and tumorigenesis, we have constructed a novel series of
wild-type and mutant Rb promoter-LacZ transgenic
reporter lines that allow us to visualize the activity of a crucial E2F
target in vivo, the retinoblastoma tumor suppressor gene (Rb).
Two mutant Rb promoter-LacZ constructs were used to
evaluate the importance of a single E2F site or a nearby activator
(Sp1/Ets) site that is found mutated in low-penetrance retinoblastomas.
The activity of the wild-type Rb promoter is dynamic, varying
spatially and temporally within the developing nervous system. While
loss of the activator site silences the Rb promoter, loss of
the E2F site stimulates its activity in the neocortex, retina, and
trigeminal ganglion. Surprisingly, E2F-mediated repression of
Rb does not act globally or in a static manner but, instead,
is a highly dynamic process in vivo. Using neocortical extracts, we
detected GA-binding protein
(GABP
, an Ets family member) bound to the activator site and both E2F1 and E2F4 bound to the repressor site of the Rb promoter in vitro. Additionally, we detected binding of both E2F1 and E2F4 to the Rb promoter in
vivo using chromatin immunoprecipitation analysis on embryonic day 13.5
brain. Unexpectedly, we detect no evidence for Rb promoter
autoregulation in neuroendocrine tumors from
Rb+/;
RbP-LacZ mice that undergo loss of heterozygosity at the
Rb locus, in contrast to the situation in human
retinoblastomas where high RB mRNA levels are found. In
summary, this study provides the first demonstration that loss of an
E2F site is critical for target gene repression in vivo and underscores
the complexity of the Rb and E2F family network in
vivo.
Supplemental material for this article may be found at http://mcb.asm.org/.
Present
address: Department of Infectious Diseases, King's College, London SE1 9RT, United Kingdom.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»